The Danish drugmaker’s patent lawsuit is the company’s latest effort to shore up its place in the booming weight-loss drug market.
Source link
About The Author
Novo Nordisk’s latest salvo against Hims & Hers—a patent-infringement lawsuit—shows the fierce maneuvering over the booming obesity-drug market